TrialBritish journal of cancer2010

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma.

A Younes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.